ABO-302

N/A

Report date: 2025/01/26 15:12:15

Base Information

Drug NameABO-302
Drug Alias NameAAV9-delivered gene therapy (Abeona Therapeutics)ABO-302
ClassificationBiologics
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsGenetic Diseases, Inborn
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesAbeona Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesAbeona Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsGenetic Diseases, Inborn
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A